tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS
CRVS
Corvus Pharmaceuticals
Stock Analysis
Analyst Forecasts
Technical Analysis
Options
Chart
Earnings
Dividends
Ownership
Financials
News & Insights
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Corvus Pharmaceuticals (CRVS) Stock News & Sentiment

469 Followers
Corvus Pharmaceuticals price target raised to $8 from $7 at Oppenheimer
PremiumThe Fly
Corvus Pharmaceuticals price target raised to $8 from $7 at Oppenheimer
2d ago
CRVS
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
PremiumPress Releases
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
3d ago
CRVS
CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5d ago
CRVS
Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024
PremiumPress Releases
Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024
7d ago
CRVS
Corvus Pharmaceuticals announces pricing of $30.6M registered direct offering
PremiumThe Fly
Corvus Pharmaceuticals announces pricing of $30.6M registered direct offering
7d ago
CRVS
Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering
PremiumPress Releases
Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering
7d ago
CRVS
Corvus initiates placebo-controlled phase 1 soquelitinib clinical trial
PremiumThe Fly
Corvus initiates placebo-controlled phase 1 soquelitinib clinical trial
30d ago
CRVS
More CRVS News >

CRVS News on the Web

Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024
Yahoo Finance
Neutral
Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering
Yahoo Finance
Neutral
Here's Why Corvus is Poised for a Turnaround After Losing -25% in 4 Weeks
Yahoo Finance
Neutral
Here's Why Corvus (CRVS) is Poised for a Turnaround After Losing -25% in 4 Weeks
Zacks
Neutral
Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
Yahoo Finance
Neutral
Down -18.35% in 4 Weeks, Here's Why Corvus Looks Ripe for a Turnaround
Yahoo Finance
Neutral
Down -18.35% in 4 Weeks, Here's Why Corvus (CRVS) Looks Ripe for a Turnaround
Zacks
Neutral
Hold Rating Maintained for Corvus Pharmaceuticals Amid Clinical Delays and Financing Concerns
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
CRVS
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CRVS’s Media Buzz Sentiment?
2 articles about CRVS were published this week. In an average week, 1 articles are published.
    What is CRVS’s weekly average amount of articles?
    In an average week, 1 articles about CRVS are published.
      What is CRVS’s News Sentiment?
      50% of articles about CRVS were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        AMRXAmneal Pharmaceuticals
        AMGNAmgen
        LUNGPulmonx
        UTHRUnited Therapeutics
        GOSSGossamer Bio
        Showing the stocks with the most bullish news sentiment over the past week

        Get More with TipRanks Premium

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing